SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs breakout to a new 52-week high and bullish call-option activity are drawing attention ahead of the expected Q3 report, with traders watching BRIUMVIs sales momentum and guidance. Buyout speculation is adding to the excitement, but remains unconfirmed; some investors see the move as earnings positioning while others question whether expectations are already priced in.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Roots Hyundai Secure+ white-label insurance offering is drawing attention, with traders viewing the dealership channel as a potential source of policy growth while others question how quickly it will convert into business. The debate is set against concern about recent declines in policies in force and sluggish revenue growth, despite continued profitability.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

OXYs breakout to a six-month high and call-heavy options activity have drawn attention, alongside optimism that debt reduction and stronger free cash flow are improving the oil producers outlook. Traders are split between expecting further momentum and cautioning that the shares could stall after lagging crude at times.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1983 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Chenieres strong Q3 results, raised full-year guidance, dividend increase, and completion of its Corpus Christi expansion are driving attention as shares reach a new high. Many traders are bullish on the operating momentum, while some are taking profits or pointing to put-heavy options activity and the risk of a pause after the run-up.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron is drawing attention after a third-quarter earnings beat, with growth in Dupixent and Eylea HD helping offset pressure on legacy Eylea. Traders largely welcomed the results and sharp share move, while some question whether newer products can sustain growth amid biosimilar competition.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotifys latest quarterly report has driven attention: despite revenue and earnings coming in below expectations, subscriber growth, stronger gross margins, and a better-than-expected next-quarter profit outlook have been credited for the stocks sharp rise. Traders are debating the disconnect between the headline miss and the upbeat guidance, with some questioning whether higher expenses and the recent run-up make the rally sustainable.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA filing for sonelokimab in hidradenitis suppurativa and the pending FDA acceptance and review-timeline decision are the main focus, with traders debating whether regulatory progress can revive the stock. Bulls point to the clinical data and commercial potential, while bears emphasize approval risk and the costs of launching alone; buyout talk remains speculative.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Positive Phase 3 data for Amgens cancer and Sjgrens disease programs are reinforcing bullish momentum as the shares approach highs. Traders are also focused on upcoming quarterly results, with some viewing put activity as earnings protection rather than a bearish bet.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is drawing attention as traders position for further Nasdaq weakness, citing tech and AI-spending concerns alongside market volatility. Some expect a deeper selloff, while others warn that reports of a possible U.S.-Iran deal and Strait of Hormuz reopening could fuel a rebound and hurt short positions.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,811.032761 with 281,866,747.320393 in circulation. The last known price of OFFICIAL TRUMP is 1.57555883 USD and is down -1.93 over the last 24 hours. It is currently trading on 744 active market(s) with $126,884,732.61 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

The Trump-branded meme coin is drawing attention amid discussion of its steep decline and retail holders losses, with many traders calling it a cash grab. A smaller bullish contingent points to the recent bounce and speculates about an election-linked rebound or short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Earnings Preview: Advance Auto Parts (AAP) Q3 Earnings Expected to Decline

Advance Auto Parts (AAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Advance Auto Parts vs. Five Below: Expand or Revamp? Which Retailer's Strategy for 2026 Will Pay Off for Investors?

Key PointsAdvance Auto Parts maintains a massive network of over 4,300 stores focused on the essential professional repair market...

Advance Auto Parts Turnaround Gains Traction, but Analysts Still See Execution Risks

BofA stays cautious on Advance Auto Parts with an Underperform rating, warning AAP continues to lag AutoZone and O'Reilly.read more...

Advance Auto Parts vs. Etsy: Which Consumer Stock Is a Better Buy in 2026?

Key PointsAdvance Auto Parts is navigating a turnaround while maintaining a balanced split between professional and DIY customers...

Advance Auto Parts vs. Booking Holdings: Which Consumer Stock Is a Better Buy in 2026?

Key PointsAdvance Auto Parts is executing a restructuring plan to optimize its supply chain and refocus on its core automotive aftermarket customers...

Advance Auto Parts vs. Dick's Sporting Goods: Are Consumers Focusing on Car Repair or Exercise More in 2026?

Key PointsAdvance Auto Parts serves a dual market of professional installers and do-it-yourself car owners through its extensive store network...

Advance Auto Parts vs. Coupang: Which Stock Is a Better Buy in 2026?

Key PointsAdvance Auto Parts is navigating a comprehensive restructuring to stabilize its automotive retail operations...

Here's Why Advance Auto Parts (AAP) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Advance Auto Parts vs. Uber Technologies: Fix the Car or Ride in It? Which Stock Is a Better Buy in 2026?

Key PointsAdvance Auto Parts serves a dual market of professional installers and hobbyists while undergoing a strategic recovery phase...

Advance Auto Parts vs. Airbnb: Which Consumer Stock Is a Better Buy in 2026?

Key PointsAdvance Auto Parts operates a vast network of stores serving both professional repair shops and individual car owners...

Advance Auto Parts, Inc. engages in the supply and distribution of aftermarket automotive products for both professional installers and do-it-yourself customers. It operates through the United States and Canada geographical segments. The company was founded by Arthur Taubman in 1929 and is headquartered in Raleigh, NC.

Advance Auto Parts Inc

AAP Stock Draws Barrage Of Price Target Hikes After Q1 Report – This Analyst Believes 'The Stock Deserves To Trade Up'

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>For the first quarter, net sales were flat at $2.6 billion, while adjusted earnings per share were $0.77.</li><li>For 2026, the company guided adjusted EPS to $2.40 to $3.10 per share, and revenue in the $8.49 billion to $8.58 billion range.</li><li>19 of the 25 analysts covering the stock rated it a ‘Hold,’ three rate it ‘Buy’ and three ‘Sell’ or lower, according to Koyfin data.</li></ul>Shares of Advance Auto Parts (AAP) extended gains on Friday after at least three analysts maintained their ratings and raised their price targets following the company’s first-quarter results.&nbsp;However, most remained cautious on the durability of the company’s turnaround.At the time of writing, AAP stock was up marginally. In its last trading session, the stock closed with more than 14% gains, its best one-day percentage performance in a year.<h1 class="st-heading-1">Wall Street Sees Progress, But Not A Full Turnaround Yet</h1>Although Goldman Sachs noted the company’s stronger-than-expected quarter, driven by improved comparable sales and margins, it remains skeptical about the pace of its turnaround and long-term margin recovery, according to TheFly.The firm maintained its ‘Sell’ rating with a price target of $54, up from $49, implying nearly 8% downside potential as of the stock’s last close on Thursday, while also suggesting that rivals AutoZone (AZO) and O'Reilly Automotive (ORLY) are better positioned to gain market share.“The stock deserves to trade up after the company posted its strongest comparable-store sales in five years, with notable gross margin and EBIT percentage progress,” said Wells Fargo, per TheFly. “But the bears still have ammo via slightly wider underperformance vs. O'Reilly Automotive (ORLY), softening quarter-to-date and still negative free cash flow.”Wells Fargo, along with Citi, kept their neutral-equivalent rating on AAP stock but raised their respective price targets to $60, implying upside potential of a little over 2%.<h1 class="st-heading-1">AAP Q1 At A Glance</h1>The company’s net sales were flat at $2.6 billion for the first quarter, ahead of the $2 billion consensus, while adjusted earnings per share (EPS) of $0.77 fell short of the $0.83 consensus, according to Fiscal AI estimates.For 2026, it guided adjusted EPS to $2.40 to $3.10 per share, with the midpoint below the $2.86 estimate, and revenue to $8.49 billion to $8.58 billion, with the midpoint below the $8.56 billion estimate.<h1 class="st-heading-1">What Retail Thinks About AAP</h1>On Stocktwits, retail sentiment about AAP turned ‘extremely bullish’ from ‘neutral’ over the last 24 hours.Wall Street, on the other hand, is largely ‘Neutral’ on the stock, with 19 of the 25 analysts rating it a ‘Hold,’ three rate it ‘Buy’ and three ‘Sell’ or lower, according to Koyfin data.<a href="https://stocktwits.com/symbol/AAP">AAP stock</a> is up more than 49% so far this year and more than 87% over the past 12 months, outperforming the S&amp;P 500.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Advance Auto Parts logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Shares of Advance Auto Parts (AAP) extended gains on Friday after at least three analysts maintained their ratings and raised their price targets following the company’s first-quarter results. Though most remained cautious on the durability of the company

AAP Stock Snags Price Target Hikes After Q1 Beat – But Analysts Question Pace Of Turnaround 

Analysts acknowledged signs of operational progress but stopped short of turning bullish on the stock.

Autozone Inc.

O`Reilly Automotive, Inc.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

AAP News